特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
949599

ホジキンリンパ腫治療の世界市場:2020~2026年

Global Hodgkin Lymphoma Treatment Market 2020-2026

出版日: | 発行: Orion Market Research Pvt Ltd | ページ情報: 英文 | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.84円
ホジキンリンパ腫治療の世界市場:2020~2026年
出版日: 2020年06月18日
発行: Orion Market Research Pvt Ltd
ページ情報: 英文
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のホジキンリンパ腫治療の市場は予測期間中に大幅な成長を示すと予測されています。先進治療への高い需要と先進諸国での高い受け入れ率、ホジキンリンパ腫診断に対する認知度の高まりなどの要因が同市場の成長を推進する見通しです。米国国立がん研究所(NCI)によると、2017年には米国で8,000人以上がホジキンリンパ腫と診断されており、診断数の増加は効率的な治療に対する需要を生み出し、同市場の成長を後押しすることとなるだろうと推測されています。

当レポートでは、世界のホジキンリンパ腫治療の市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、関連法規制、市場規模の推移・予測、治療区分など各種区分別の内訳、地域・主要国別の詳細分析、競合環境、企業シェア、主要企業のプロファイルなどをまとめています。

第1章 レポート概要

第2章 市場概要・考察

  • 調査範囲
  • アナリストの見解・現在の市場動向
  • 法規制

第3章 競合情勢

  • 企業シェア分析
  • 主要戦略の分析
  • 主要企業の分析

第4章 市場影響因子

  • 成長推進因子
  • 成長抑制因子
  • 市場機会

第5章 市場分析・予測:各種区分別

  • タイプ別
    • 放射線治療
    • 免疫療法
    • 化学療法
    • その他(幹細胞移植)

第6章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • その他
  • その他の地域

第7章 企業プロファイル

  • Bristol-Myers Squibb Co.
  • Fresenius Kabi USA, LLC
  • Genentech Inc.
  • Healthgrades Operating Company, Inc.
  • Hikma Pharmaceuticals PLC
  • Leadiant Biosciences, Inc.
  • LGM Pharma, LLC
  • Merck & Co. Inc.
  • Mylan N.V.
  • NextSource Biotechnology, LLC
  • Pfizer, Inc.
  • Recordati Rare Diseases, Inc.
  • Seattle Genetics. Inc.
  • Takeda Pharmaceutical Co. Ltd.
  • Teva Pharmaceuticals Industries, Ltd.
図表

LIST OF TABLES

  • 1. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 2. GLOBAL RADIATION THERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 3. GLOBAL IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 4. GLOBAL CHEMOTHERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 5. GLOBAL OTHERS HODGKIN LYMPHOMA TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2015 ($ MILLION)
  • 6. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2019-2026 ($ MILLION)
  • 7. NORTH AMERICAN HODGKIN LYMPHOMA TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 8. NORTH AMERICAN HODGKIN LYMPHOMA TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 9. EUROPEAN HODGKIN LYMPHOMA TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 10. EUROPEAN HODGKIN LYMPHOMA TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 11. ASIA-PACIFIC HODGKIN LYMPHOMA TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 12. ASIA-PACIFIC HODGKIN LYMPHOMA TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 13. REST OF THE WORLD HODGKIN LYMPHOMA TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SHARE BY TYPE, 2019 VS 2026 (%)
  • 2. GLOBAL HODGKIN LYMPHOMA TREATMENT MARKET SHARE BY GEOGRAPHY, 2019 VS 2026 (%)
  • 3. US HODGKIN LYMPHOMA TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 4. CANADA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 5. UK HODGKIN LYMPHOMA TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 6. FRANCE HODGKIN LYMPHOMA TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 7. GERMANY HODGKIN LYMPHOMA TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 8. ITALY HODGKIN LYMPHOMA TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 9. SPAIN HODGKIN LYMPHOMA TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 10. ROE HODGKIN LYMPHOMA TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 11. INDIA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 12. CHINA HODGKIN LYMPHOMA TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 13. JAPAN HODGKIN LYMPHOMA TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 14. REST OF ASIA-PACIFIC HODGKIN LYMPHOMA TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 15. REST OF THE WORLD HODGKIN LYMPHOMA TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
目次
Product Code: OMR2021918

Global Hodgkin Lymphoma Treatment Market Size, Share & Trends Analysis Report, by Type (Radiation therapy, Immunotherapy, Chemotherapy, and Others), and Forecast Period, 2020-2026.

The global Hodgkin lymphoma treatment market is estimated to grow significantly during the forecast period. Hodgkin lymphoma is cancer originates from specific white blood cells (WBC), also known as lymphocytes. Symptoms such as fever, weight loss and night sweat are some non-painful enlarged nodes generally took place under the arm, the neck and in the inguinal region. The growing demand for advanced Hodgkin lymphoma treatment along with a high acceptance rate in developed nations and an increase in awareness about the Hodgkin lymphoma diagnosis is fueling the market growth during the forecast period. According to the National Cancer Institute (NCI), more than 8,000 people in the US were diagnosed with Hodgkin lymphoma in 2017. Hence, a growing number of diagnoses will create demand for efficient treatment which will boost the Hodgkin lymphoma treatment market.

The global Hodgkin lymphoma treatment market is segmented based on type. Based on type, the market is classified into radiation therapy, immunotherapy, chemotherapy, and others (stem cell transplant). There are various drugs available in the market for the treatment of Hodgkin lymphoma. These drugs include Adcetris (Brentuximab Vedotin), BiCNU (Carmustine), Brentuximab Vedotin, Carmustine, Cyclophosphamide, Dacarbazine, Adriamycin (doxorubicin), Bleomycin, Vinblastine and Dacarbazine (DTIC).

Geographically, the global Hodgkin lymphoma treatment market is classified into North America, Europe, Asia-Pacific, and the Rest of the world. North America is estimated to witness significant growth in the market and is expected to retain its dominance in the coming years. The major companies providing Hodgkin lymphoma treatment include Bristol-Myers Squibb Co., Pfizer, Inc., Hikma Pharmaceuticals PLC, Merck & Co. Inc., Takeda Pharmaceutical Co. Ltd., Fresenius Kabi USA, LLC, Genentech Inc., Leadiant Biosciences, Inc., and LGM Pharma, LLC.

Research Methodology

The market study of the global Hodgkin lymphoma treatment market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Authentic public databases
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation:

  • Global Hodgkin Lymphoma Treatment Market Research and Analysis by Treatment

The Report Covers:

  • Comprehensive research methodologies of the global Hodgkin lymphoma treatment market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global Hodgkin lymphoma treatment market.
  • Insights about market determinants which are stimulating the global Hodgkin lymphoma treatment market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. Bristol-Myers Squibb Co.
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. SWOT Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. Pfizer, Inc.
      • 3.3.2.1. Overview
      • 3.3.2.2. Financial Analysis
      • 3.3.2.3. SWOT Analysis
      • 3.3.2.4. Recent Developments
    • 3.3.3. Hikma Pharmaceuticals PLC
      • 3.3.3.1. Overview
      • 3.3.3.2. Financial Analysis
      • 3.3.3.3. SWOT Analysis
      • 3.3.3.4. Recent Developments
    • 3.3.4. Merck & Co. Inc.
      • 3.3.4.1. Overview
      • 3.3.4.2. Financial Analysis
      • 3.3.4.3. SWOT Analysis
      • 3.3.4.4. Recent Developments
    • 3.3.5. Takeda Pharmaceutical Co. Ltd.
      • 3.3.5.1. Overview
      • 3.3.5.2. Financial Analysis
      • 3.3.5.3. SWOT Analysis
      • 3.3.5.4. Recent Developments

4. Market Determinants

  • 4.1 Motivators
  • 4.2 Restraints
  • 4.3 Opportunities

5. Market Segmentation

  • 5.1. Global Hodgkin Lymphoma Treatment Market by Type
    • 5.1.1. Radiation therapy
    • 5.1.2. Immunotherapy
    • 5.1.3. Chemotherapy
    • 5.1.4. Others (Stem Cell Transplant)

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Bristol-Myers Squibb Co.
  • 7.2. Fresenius Kabi USA, LLC
  • 7.3. Genentech Inc.
  • 7.4. Healthgrades Operating Company, Inc.
  • 7.5. Hikma Pharmaceuticals PLC
  • 7.6. Leadiant Biosciences, Inc.
  • 7.7. LGM Pharma, LLC
  • 7.8. Merck & Co. Inc.
  • 7.9. Mylan N.V.
  • 7.10. NextSource Biotechnology, LLC
  • 7.11. Pfizer, Inc.
  • 7.12. Recordati Rare Diseases, Inc.
  • 7.13. Seattle Genetics. Inc.
  • 7.14. Takeda Pharmaceutical Co. Ltd.
  • 7.15. Teva Pharmaceuticals Industries, Ltd.
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.